Clear Proof Acne System The Go Set Kit
RxNorm Crosswalk NDC 51531-8968

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Clear Proof Acne System The Go Set (NDC 51531-8968) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 8 unique RxNorm concepts. By anchoring Mary Kay Inc.'s product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

salicylic acid 20 MG/ML Topical Solution
(RxCUI 251577)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

benzoyl peroxide 0.05 MG/MG Topical Gel
(RxCUI 308694)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

salicylic acid 20 MG/ML Medicated Liquid Soap
(RxCUI 562600)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSN
Featured Concept

clearproof Acne Treatment 5 % Topical Gel
(RxCUI 1489132)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSN
Featured Concept

clearproof acne medication 2 % Topical Solution
(RxCUI 1491648)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSN
Featured Concept

clearproof Clarifying 2 % Medicated Liquid Soap
(RxCUI 1493165)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSN
Featured Concept

benzoyl peroxide 5 % Topical Gel (3 GM) / salicylic acid 2 % Medicated Liquid Soap (28 GM) / salicylic acid 2 % Topical Solution (26 ML) Pack
(RxCUI 1493511)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSN
Featured Concept

MARY KAY clear proof acne to-go system Pack
(RxCUI 1493512)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Clear Proof Acne System The Go Set

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 51531-8968 to RxCUI 1489132, 1491648, 1493165, 1493511, 1493512, 251577, 308694, 562600, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SBD Semantic Branded Drug: The branded equivalent representing the Brand Name + Strength + Dosage Form.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • GPCK Generic Pack: A standardized concept for a clinical kit containing multiple generic components.
  • BPCK Branded Pack: A standardized concept for a clinical kit containing multiple branded components.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

* Please review the full disclaimer at the bottom of this page.